Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets

Dublin Core

Title

Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets

Subject

BIOEQUIVALENCIA
EVAVIRENZ
BIBLIOGRAFIA NACIONAL QUIMICA
2016

Abstract

Although sex-related differences in gastrointestinal physiology have been vastly reported, its impact on drug oral
bioavailability and bioequivalence (product discrimination) is often ignored. On this work results from an
average bioequivalence study between tablets containing 600 mg of the antiretroviral efavirenz (EFV), carried
out with 14 healthy subjects (8 female and 6 men) in a randomized 2-period, 2-treatment crossover design,
are analyzed from a sex-based approach. Sequences were balanced within each sex group. Considering all
subjects, no differences were observed on EFV absorbed amount, as shown by the estimated 90CI of the AUC96
Test/Reference bioequivalence ratio (T/R): 0.950–1.05. However, results were not conclusive due to the 90CI
for CMAX T/R was 0.743–1.07. Over this parameter, a significant sex-by-formulation interaction was detected:
90CI CMAX T/R was 0.838–1.36 in women and 0.540–0.920 in men; with a 52% relative difference between
point estimates. Formulation differences were therefore evidenced only by male subjects. In vitro dissolution
and disintegration tests for both products were carried out in two aqueous media: A) SLS 0.25% and B) HCl/KCl
pH 1.2. T/R results for dissolution efficiency and tablet disintegration times of formulations in both A and B
media were highly correlated with CMAX T/R bioequivalence results observed in women and men respectively,
showing that a dissimilar gastrointestinal environment between sexes affected EFV oral absorption. This work
shows how sex-by-formulation interaction can affect bioequivalence conclusions. Sex effect on product discrimination
should be specially disclosed in bioequivalence studies, mainly for drugs aimed to be given to both sexes.

Creator

Ibarra, Manuel
Magallanes, Laura
Lorier, Marianela
Vázquez, Marta

Source

European Journal of Pharmaceutical Sciencesv. 85, 2016. -- p. 106-111

Publisher

Elsevier

Date

2016

Rights

Información sobre Derechos de Autor

(Por favor lea este aviso antes de abrir los documentos u objetos)

La legislación uruguaya protege el derecho de autor sobre toda creación literaria, científica o artística, tanto en lo que tiene que ver con sus derechos morales, como en lo referente a los derechos patrimoniales con sujeción a lo establecido por el derecho común y las siguientes leyes

(LEY 9.739 DE 17 DE DICIEMBRE DE 1937 SOBRE PROPIEDAD LITERARIA Y ARTISTICA CON LAS MODIFICACIONES INTRODUCIDAS POR LA LEY DE DERECHO DE AUTOR Y DERECHOS CONEXOS No. 17.616 DE 10 DE ENERO DE 2003, LEY 17.805 DE 26 DE AGOSTO DE 2004, LEY 18.046 DE 24 DE OCTUBRE DE 2006 LEY 18.046 DE 24 DE OCTUBRE DE 2006)

ADVERTENCIA - La consulta de este documento queda condicionada a la aceptación de las siguientes condiciones de uso: Este documento es únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con fines de lucro. Esta reserva de derechos afecta tanto los datos del documento como a sus contenidos. En la utilización o cita de partes debe indicarse el nombre de la persona autora.

Format

PDF

Language

Inglés

Type

Artículo

Identifier

http://dx.doi.org/10.1016/j.ejps.2016.02.001

Document Item Type Metadata

Original Format

PDF
Date Added
May 6, 2016
Collection
Bibliografía Nacional Química
Item Type
Document
Tags
,
Citation
Ibarra, Manuel et al., “Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets,” RIQUIM - Repositorio Institucional de la Facultad de Química - UdelaR, accessed November 17, 2025, https://riquim.fq.edu.uy/items/show/3961.